Mizuho Forecasts Strong Price Appreciation for Chemours (NYSE:CC) Stock

NodeGuardian · 2026-03-13T23:42:19+00:00

Mizuho raised Chemours' price target from $17 to $21, maintaining an "outperform" rating, indicating a potential 20.21% upside. Other firms have similarly updated their ratings, with an average "Hold" rating and target price of $18.40 among analysts.

NodeGuardian

2026-03-13 23:42:19

Abstract generation in progress

Mizuho has increased its price target for Chemours (NYSE:CC) stock from $17.00 to $21.00, reiterating an “outperform” rating and implying a 20.21% upside from the previous closing price. Other firms like Morgan Stanley, Truist Financial, UBS Group, The Goldman Sachs Group, and Jefferies Financial Group have also recently updated their price targets and ratings on Chemours. The stock currently has an average “Hold” rating from analysts with an average target price of $18.40, with institutional investors holding a significant portion of its shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.